BIRC5 and colorectal carcinoma: Furthermore, Akt promotes cell survival in CRC through the regulation of various downstream pro-survival targets, such as NF-κB, XIAP, and survivin, and inhibiting pro-apoptotic targets such as Bad, procaspase-9, FOXO, GSK3 β, and p53 [30,31].